Allmed Medical(SZ:002950) Zheng Quan Shi Bao Wang·2025-07-31 13:43Core Viewpoint - Aomei Medical has signed a comprehensive cooperation agreement with Lohmann & Rauscher Group, marking a significant strategic partnership that includes the acquisition of Lohmann & Rauscher's wholly-owned subsidiary in China and exclusive agency rights for various medical products in the region [1][2]. Group 1: Strategic Partnership - The partnership involves Aomei Medical acquiring 100% of Lohmann & Rauscher (China) Medical Supplies Co., Ltd. and gaining exclusive agency rights for wound management, pressure treatment, and external fixation products in China [1]. - This collaboration is a continuation of their strategic cooperation that began with a functional dressing business partnership in November 2024, further solidifying their multi-layered strategic alliance [1][2]. Group 2: Market Position and Product Development - Aomei Medical has been focusing on the research and manufacturing of functional dressings, launching innovative products such as soft silicone foam dressings and hydrocolloid dressings, which cater to various wound care scenarios [2]. - The partnership enhances Aomei Medical's product pipeline in the wound management sector and allows entry into new fields like pressure treatment and external fixation, significantly boosting its competitive edge in the Chinese market [2]. Group 3: Leadership Perspectives - The CEO of Lohmann & Rauscher Group expressed confidence that the partnership will lead to higher quality and more sustainable product development, highlighting Aomei Medical's production capabilities [2]. - Aomei Medical's chairman emphasized that this collaboration marks a new beginning in the healthcare sector, aiming for significant achievements in expanding their market presence in China [3].